Paperpal Prime Logo

Journal of Oncology : Impact Factor & More

eISSN: 1687-8469pISSN: 1687-8450

Key Metrics

CiteScore
4
Eigenfactor
0.001 - 0.005
H-Index
64
Impact Factor
< 5
Scite Index
0.87 5-Year SI
SJR
Q2Oncology
SNIP
1.07
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Oncology

Journal of Oncology Journal Specifications

Overview
Publisher Hindawi

Planning to publish in Journal of Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Oncology

RETRACTION: Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5\u2010Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta\u2010Analysis and Systematic Review
  • 7 Aug 2026
  • Journal of Oncology
Correction to \u201cInitial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines\u201d
  • 29 Jul 2026
  • Journal of Oncology
RETRACTION: Nrf3 Promotes 5\u2010FU Resistance in Colorectal Cancer Cells via the NF\u2010\u03baB/BCL\u20102 Signaling Pathway In Vitro and In Vivo
  • 16 Jul 2026
  • Journal of Oncology
Correction to \u201cClusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF\u2010\u03baB\u2010Dependent Mechanism\u201d
  • 31 May 2026
  • Journal of Oncology
Title not available
  • 1 Jan 2026
  • Journal of Oncology
RETRACTION: P4HA2 Promotes Epithelial-to-Mesenchymal Transition and Glioma Malignancy through the Collagen-Dependent PI3K/AKT Pathway.
  • 1 Jan 2026
  • Journal of oncology
RETRACTION: Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5\u2010Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta\u2010Analysis and Systematic Review
  • 7 Aug 2026
  • Journal of Oncology
Correction to \u201cInitial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines\u201d
  • 29 Jul 2026
  • Journal of Oncology
RETRACTION: Nrf3 Promotes 5\u2010FU Resistance in Colorectal Cancer Cells via the NF\u2010\u03baB/BCL\u20102 Signaling Pathway In Vitro and In Vivo
  • 16 Jul 2026
  • Journal of Oncology
Correction to \u201cClusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF\u2010\u03baB\u2010Dependent Mechanism\u201d
  • 31 May 2026
  • Journal of Oncology
Title not available
  • 1 Jan 2026
  • Journal of Oncology
RETRACTION: P4HA2 Promotes Epithelial-to-Mesenchymal Transition and Glioma Malignancy through the Collagen-Dependent PI3K/AKT Pathway.
  • 1 Jan 2026
  • Journal of oncology

FAQs on Journal of Oncology